Surrogate McKenna West has asked the U.S. Supreme Court to block the biological parents from moving the Dallas-born infant out of Texas while her petition is pending. Multiple outlets, including the New York Post, Fox News, and Audacy, reported on West's fear that the child could be relocated before the Court acts. The case centers on West's refusal to terminate the pregnancy and her ongoing fight over the baby's custody and care.
This case is moving fast. If you are a surrogate or intended parent mid-contract, it is a timely reminder to confirm with your attorney exactly what jurisdiction provisions your agreement contains and what they mean if a dispute arises.
Rep. Tim Burchett has publicly sounded the alarm about what he is calling a Chinese surrogacy loophole, citing the case of billionaire Xu Bo and his alleged network of hundreds of U.S.-born children. Multiple outlets continued to flesh out details of how the surrogacy network operated, including accounts from surrogates who say they had no idea who the biological father was. The story is now drawing scrutiny from both lawmakers and national security commentators.
The political attention this story is attracting will almost certainly accelerate calls for new disclosure requirements in commercial surrogacy contracts. Worth watching closely.
A follow-up from CBS News and its affiliate cbs19.tv reinforced the findings of the network's ongoing investigation into surrogacy industry safeguards, highlighting alarming patterns across agencies and clinics. The reporting points to uneven oversight, inadequate screening practices, and gaps that leave both surrogates and intended parents exposed. The investigation has now drawn broader regional pickup.
If you are currently working with an agency, it is worth asking directly: how are surrogates screened, who holds the escrow funds, and what happens if the agency closes? These are not alarmist questions. They are standard due diligence.
A group of UK Members of Parliament, as reported by The Christian Institute, have signed a declaration stating they reject what they describe as the commodification of mothers and babies through surrogacy. The move comes amid sustained pressure on the UK government over its refusal to legislate on surrogacy reform. It signals a growing abolitionist bloc within Westminster, distinct from those calling for regulated access.
The UK debate continues to sharpen into two opposing camps: those pushing for regulated pathways and those pushing for prohibition. Neither outcome is imminent, but intended parents exploring UK surrogacy should track this closely.
LGBTQ Nation profiled a gay couple who successfully challenged their employer to cover surrogacy costs, ultimately becoming fathers to two children. The couple has since written a children's book about their experience. Their story illustrates both the barriers LGBTQ families face in accessing fertility benefits and what persistence through that process can look like.
This one is worth sitting with. A story about what is possible when families push back on coverage denials, and document the journey for others.
The most striking thread today is the collision between individual surrogacy stories and national security language. The McKenna West case has been a custody and bodily autonomy story from the start, but the Chinese billionaire network is pulling surrogacy into a different register entirely, one where lawmakers are using terms like loopholes and domestic security threats. That framing has consequences: it tends to produce fast, broad legislative responses that can reshape the landscape for everyone in it, not just the bad actors.
Know ThisThe HOPE Act and Federal Fertility Insurance Coverage
The HOPE Act — short for the Health Options for People through Expanded Reproductive Services Act — is a proposed piece of federal legislation that would require private health insurers across the United States to cover a broad range of fertility treatments. If passed, it would mark the most significant expansion of reproductive healthcare coverage in the country's history, bringing meaningful financial relief to millions of people who currently face enormous out-of-pocket costs on their path to parenthood.
At its core, the HOPE Act would mandate coverage for diagnostics, in vitro fertilization, egg freezing, embryo cryopreservation, and other medically recognized fertility treatments. Importantly, the bill is written with inclusive language that would extend these protections to same-sex couples and single individuals, not just married heterosexual couples — a limitation that has plagued many existing state-level mandates.
That distinction matters enormously. Today, only about 20 states require insurers to offer some form of fertility coverage, and the scope, quality, and eligibility rules vary widely from state to state. A person living in a state with no mandate has essentially no guaranteed coverage, regardless of their employer or plan type. The HOPE Act would establish a consistent federal floor, meaning your zip code would no longer determine whether your fertility journey is financially supported.
As of now, the HOPE Act has been introduced in Congress but has not yet been signed into law. Its progress has been gradual, and advocates continue to push for its advancement.
For surrogacy families specifically, passage of the HOPE Act could help cover the IVF cycles needed to create embryos — one of the most significant costs in the surrogacy process. While it would not directly cover a surrogate's medical expenses, reducing the financial burden on intended parents at the embryo creation stage would be a genuinely life-changing step forward.
Get this brief in your inbox every morning.
One email, the stories that matter for your journey, explained.